New drug combo tested for aggressive leukemia relapse
NCT ID NCT05799079
Summary
This study tested whether a combination of three drugs could help control acute myeloid leukemia (AML) that has returned after a stem cell transplant. The trial aimed to see if the treatment could put the cancer back into remission and extend survival. The study was terminated early after enrolling only one participant, so no conclusions could be drawn about effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.